Risk of death in elderly users of conventional vs. atypical antipsychotic medications
Wang PS, Schneeweiss S, Avorn J et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005 353 : 2335 2341.
NDA 20-919 (Haloperidol). QT Prolongation in Association with the Use of Haloperidol Decanoate: A Response to the Pharmacovigilance Department of the Italian Drug Agency. Prepared by Johnson & Johnson Pharmaceutical Research and Development, L.L.C. Dated October 2005 [on-line]. Available at. Accessed September 25, 2007.
NDA 20-919 (Haloperidol). QT Prolongation in Association with the Use of Haloperidol Decanoate: A Response to the Pharmacovigilance Department of the Italian Drug Agency. Prepared by Johnson & Johnson Pharmaceutical Research and Development, L.L.C. Dated October 2005 [on-line]. Available at Accessed September 25, 2007.
3
53149085840
Information for Healthcare Professionals: Haloperidol [on-line]. Available at. Accessed September 25, 2007.
Information for Healthcare Professionals: Haloperidol [on-line]. Available at Accessed September 25, 2007.
4
1442306232
Drug-induced prolongation of the QT interval
Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004 350 : 1013 1022.
A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs
Kongsamut S, Kang J, Chen XL et al. A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs. Eur J Pharmacol 2002 450 : 37 41.